RMD - CONSENSUS CO - ResMed Inc.

ResMed Inc. (RMD) revenues rely on the sale of CPAP systems, consumables, and SaaS subscriptions, with margins standing at 262.38. The company is transforming its equipment into a smart environment, leveraging cloud monitoring for remote patient tracking. Low political risks and resilient logistics ensure stability. The price indicator on the chart below illustrates the price action of this specialized medical device manufacturer.

The consensus forecast represents the average target price from sector analysts, reflecting the aggregate market valuation of the asset's fair value. The stability of the consensus target within the analyst coverage confirms the business's maturity, which for ResMed Inc. (RMD) correlates with the effective implementation of digital technologies in apnea therapy and proficient supply chain management under the leadership of Mick Farrell.